| # | % | |||||
|---|---|---|---|---|---|---|
| 251 | DYNAVAX TECHNOLOGIES CORP | 5,942 | 8,663,000 | 0.45% | Put | |
| 252 | DEXCOM INC | 1,180 | 9,361,000 | 0.49% | Call | |
| 253 | SPDR SERIES TRUST | 1,858 | 10,050,000 | 0.52% | Put | |
| 254 | ABBOTT LABS | 264,700 | 10,405,000 | 0.54% | ||
| 255 | SAGE THERAPEUTICS INC | 3,496 | 10,533,000 | 0.55% | Put | |
| 256 | SAGE THERAPEUTICS INC | 4,009 | 12,079,000 | 0.63% | Call | |
| 257 | MYLAN N V | 2,804 | 12,124,000 | 0.63% | Call | |
| 258 | MEDICINES CO | 3,614 | 12,154,000 | 0.63% | Call | |
| 259 | SPDR GOLD TRUST | 1,000 | 12,652,000 | 0.66% | Call | |
| 260 | SHIRE PLC | 698 | 12,849,000 | 0.67% | Call | |
| 261 | SHIRE PLC | 698 | 12,849,000 | 0.67% | Put | |
| 262 | ABBVIE INC | 2,347 | 14,530,000 | 0.76% | Put | |
| 263 | SAREPTA THERAPEUTICS INC | 783,497 | 14,941,000 | 0.78% | ||
| 264 | ACADIA PHARMACEUTICALS INC | 4,674 | 15,172,000 | 0.79% | Call | |
| 265 | DYNAVAX TECHNOLOGIES CORP | 10,712 | 15,618,000 | 0.81% | Call | |
| 266 | RETROPHIN INC | 9,445 | 16,822,000 | 0.88% | Call | |
| 267 | TESARO INC | 2,158 | 18,138,000 | 0.95% | Call | |
| 268 | TEVA PHARMACEUTICAL INDS LTD | 3,618 | 18,173,000 | 0.95% | Call | |
| 269 | MANNKIND CORP | 52,978 | 18,271,000 | 0.95% | Put | |
| 270 | ABBOTT LABS | 5,000 | 19,655,000 | 1.03% | Put | |
| 271 | AMGEN INC | 154,082 | 23,444,000 | 1.22% | ||
| 272 | REGENERON PHARMACEUTICALS | 71,525 | 24,979,000 | 1.30% | ||
| 273 | SAREPTA THERAPEUTICS INC | 15,225 | 29,034,000 | 1.51% | Call | |
| 274 | DEXCOM INC | 4,214 | 33,430,000 | 1.74% | Put | |
| 275 | Call JNJ $125.0 Exp May 19, 2017 | 2,809 | 34,073,000 | 1.78% | Call | |
| 276 | PFIZER INC | 10,000 | 35,210,000 | 1.84% | Call | |
| 277 | LILLY ELI & CO | 4,891 | 38,517,000 | 2.01% | Put | |
| 278 | REGENERON PHARMACEUTICALS | 1,160 | 40,511,000 | 2.11% | Put | |
| 279 | BIOGEN INC | 1,866 | 45,124,000 | 2.35% | Call | |
| 280 | MONSANTO CO NEW | 5,334 | 55,159,000 | 2.88% | Call | |
| 281 | SAREPTA THERAPEUTICS INC | 29,250 | 55,780,000 | 2.91% | Put | |
| 282 | AMGEN INC | 3,942 | 59,978,000 | 3.13% | Put | |
| 283 | HCA HOLDINGS INC | 9,291 | 71,550,000 | 3.73% | Call | |
| 284 | ABBVIE INC | 18,007 | 111,481,000 | 5.82% | Call | |
| 285 | ISHARES SP 100 ETF | 13,600 | 156,359,000 | 8.16% | Put | |
| 286 | SPDR S&P 500 ETF TR PUT | 8,415 | 176,319,000 | 9.20% | Put | |
| 287 | LILLY ELI & CO | 30,121 | 237,203,000 | 12.38% | Call |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-119067, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
